Lion Biotechnologies, Inc.
SEC CIK 1425205 · N/A · last insider filing 2026-06-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Weiser Michael | Director | filed 2018 - 2026 |
| Maynard Ryan D | Director | filed 2015 - 2026 |
| Countouriotis Athena | Director | filed 2019 - 2026 |
| Dukes Iain D. | Director | filed 2016 - 2026 |
| Vogt Frederick G | Director · See Remarks | filed 2017 - 2026 |
| Yarno Wendy L | Director | filed 2023 - 2025 |
| Mcpeak Merrill A/ | Director · Interim President and CEO | filed 2011 - 2024 |
| Rothbaum Wayne P. | Director | filed 2016 - 2024 |
| Dixon Wendy L | Director | filed 2022 - 2022 |
| Fardis Maria | Director · President and CEO | filed 2016 - 2021 |
| Hillsberg Sanford | Director | filed 2013 - 2017 |
| Venkatesan Jay | Director | filed 2013 - 2017 |
| Hawkins Elma | Director · President and CEO | filed 2014 - 2016 |
| Ayer Capital Management, LP | Director | filed 2013 - 2015 |
| Handelman Michael D | Director · Chief Financial Officer | filed 2011 - 2014 |
| Singh Manish | Director · President and CEO | filed 2013 - 2014 |
| Kessler Paul L. | Director · Chair,CEO, Pres., Pr.Acctg | filed 2013 - 2013 |
| Voyticky David J | Director | filed 2013 - 2013 |
| Schroeder Martin | Director | filed 2011 - 2012 |
| Cataldo Tony | Director · CEO, President | filed 2011 - 2011 |
| Mckilligan Richard | Director · Secretary, Treasurer, CFO | filed 2010 - 2011 |
| Brooke Robert T. | Director · President, CEO | filed 2010 - 2011 |
| Coles L. Stephen | Director | filed 2011 - 2011 |
| Andrews William H | Director | filed 2011 - 2011 |
| Ahn Mark J | Director | filed 2010 - 2010 |
| Abotaleb Ibrahim | Director · President & CEO | filed 2008 - 2008 |
| Lewis Gerald | Director · Secretary Tresurer | filed 2008 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Puri Raj K. | Chief Regulatory Officer | filed 2024 - 2026 |
| Bilinsky Igor | Chief Operating Officer | filed 2021 - 2026 |
| Graf Finckenstein Friedrich | Chief Medical Officer | filed 2019 - 2026 |
| Kirby Daniel Gordon | Chief Commercial Officer | filed 2025 - 2026 |
| Roche Corleen M. | Chief Financial Officer | filed 2025 - 2026 |
| Rosinack Matthew W. | SVP, Finance (Int. PFO & PAO) | filed 2025 - 2025 |
| Bellemin Jean-Marc | Chief Financial Officer | filed 2020 - 2025 |
| Swartzburg Michael | Vice President, Finance (PAO) | filed 2020 - 2021 |
| Morris Timothy E | Chief Financial Officer | filed 2017 - 2019 |
| Valle Franco | Principal Accounting Officer | filed 2017 - 2017 |
| Schiffman Gregory T | Chief Financial Officer | filed 2016 - 2016 |
| Henderson Molly | Chief Financial Officer | filed 2015 - 2016 |
| Fischkoff Steven A. | Chief Medical Officer | filed 2016 - 2016 |
| Lotze Michael | Chief Scientific Officer | filed 2016 - 2016 |
| Bender James G. | Vice President, Manufacturing | filed 2014 - 2016 |
| Radvanyi Laszlo | Chief Scientific Officer | filed 2014 - 2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.